BRPI0510947A - tratamento de doença respiratória - Google Patents

tratamento de doença respiratória

Info

Publication number
BRPI0510947A
BRPI0510947A BRPI0510947-7A BRPI0510947A BRPI0510947A BR PI0510947 A BRPI0510947 A BR PI0510947A BR PI0510947 A BRPI0510947 A BR PI0510947A BR PI0510947 A BRPI0510947 A BR PI0510947A
Authority
BR
Brazil
Prior art keywords
respiratory disease
disease treatment
treatment
glycopyrrolate
bronchospasm
Prior art date
Application number
BRPI0510947-7A
Other languages
English (en)
Inventor
Robin Mark Bannister
Susan Snape
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of BRPI0510947A publication Critical patent/BRPI0510947A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

TRATAMENTO DE DOENçA RESPIRATóRIA O glicopirrolato ou um análogo dele é útil no tratamento do bronco-espasmo ou como medicação de emergência.
BRPI0510947-7A 2004-05-10 2005-05-10 tratamento de doença respiratória BRPI0510947A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0410398.2A GB0410398D0 (en) 2004-05-10 2004-05-10 The treatment of respiratory disease
PCT/GB2005/001776 WO2005107872A2 (en) 2004-05-10 2005-05-10 Treating respiratory diseases with gycopyrrolate and analogues

Publications (1)

Publication Number Publication Date
BRPI0510947A true BRPI0510947A (pt) 2007-11-20

Family

ID=32526759

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510947-7A BRPI0510947A (pt) 2004-05-10 2005-05-10 tratamento de doença respiratória

Country Status (14)

Country Link
US (1) US20080020048A1 (pt)
EP (1) EP1750806A2 (pt)
JP (1) JP2007536361A (pt)
CN (1) CN1950127A (pt)
AU (1) AU2005240404B2 (pt)
BR (1) BRPI0510947A (pt)
CA (1) CA2566339A1 (pt)
GB (1) GB0410398D0 (pt)
IL (1) IL178815A (pt)
MX (1) MXPA06013039A (pt)
NO (1) NO20065535L (pt)
NZ (1) NZ550911A (pt)
WO (1) WO2005107872A2 (pt)
ZA (1) ZA200609967B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
US20100055045A1 (en) 2008-02-26 2010-03-04 William Gerhart Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
CA2716936C (en) * 2008-02-26 2018-06-05 Elevation Pharmaceuticals, Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
AU2013205983A1 (en) * 2008-02-26 2013-06-13 Sunovion Respiratory Development Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US8580801B2 (en) * 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
JO3510B1 (ar) 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
WO2013137009A1 (ja) * 2012-03-14 2013-09-19 株式会社Ｌｔｔバイオファーマ 慢性閉塞性肺疾患改善剤
WO2014062143A2 (en) * 2012-10-19 2014-04-24 Mahmut Bilgic Anticholinergic agent combinations
WO2014077787A1 (en) * 2012-11-16 2014-05-22 Mahmut Bilgic Combinations including abeta2 agonist and glycopyrrolate
CA2895955A1 (en) * 2012-12-27 2014-07-03 Microdose Therapeutx, Inc. Dry powder inhalation formulation of oxybutynin and a pharmaceutically effective agent to treat respiratory disease
DK3689332T3 (da) 2014-09-09 2026-03-23 Vectura Ltd Formulering, som omfatter glycopyrrolat, fremgangsmåde og apparat
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
CN112137957B (zh) * 2019-06-26 2022-07-29 长风药业股份有限公司 一种药用吸入气雾剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
ES2309705T3 (es) * 2004-02-06 2008-12-16 MEDA PHARMA GMBH & CO. KG Nueva combinacion de anticolinergico y beta-mimeticos para el tratamiento de enfermedades respiratorias.
GB0410399D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease

Also Published As

Publication number Publication date
IL178815A (en) 2011-10-31
US20080020048A1 (en) 2008-01-24
AU2005240404B2 (en) 2009-04-23
IL178815A0 (en) 2007-05-15
WO2005107872A3 (en) 2006-03-16
NO20065535L (no) 2006-12-08
EP1750806A2 (en) 2007-02-14
CN1950127A (zh) 2007-04-18
NZ550911A (en) 2010-10-29
CA2566339A1 (en) 2005-11-17
ZA200609967B (en) 2008-06-25
AU2005240404A1 (en) 2005-11-17
JP2007536361A (ja) 2007-12-13
MXPA06013039A (es) 2007-06-19
GB0410398D0 (en) 2004-06-16
WO2005107872A2 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
BRPI0510947A (pt) tratamento de doença respiratória
ATE494904T1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
EA200702358A1 (ru) Комбинация ингибитора pde4 и производного тетрагидробиоптерина
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
ATE524479T1 (de) Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
TNSN06053A1 (en) 6-substituted anilino purines as rtk inhibitors
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
ATE495745T1 (de) 1-ä2-(2,4-dimethylphenylsulfanyl)phenylüpiperaz n als verbindung mit kombinierter serotonin- aufnahme, 5-ht3- und 5-ht1a-aktivität zur behandlung von schmerzen oder restsymptomen bei depressionen im zusammenhang mt schlaf und kognition
BRPI0510946A (pt) tratamento de asma em crianças
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE448232T1 (de) Substituierte heterozyklen
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
NO20076405L (no) Anvendelse av 24-nor-UDCA
BR0312446A (pt) 2-heteroaril carboxamidas
BRPI0605926A2 (pt) ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos
ATE547396T1 (de) Dicycloalkylcarbamoyl-harnstoffe als glucokinase- aktivatoren
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
MX2010005915A (es) Derivados de fenil-oxetanilo.
DE602005016729D1 (de) Verwendung von 5'-methylthioadenosin zur prävention und/oder behandlung von autoimmunkrankheiten und/oder transplantatabstossung
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
ATE374202T1 (de) Neue analoga von nitrobenzylthioinosin
GB0606015D0 (en) therapeutic agents
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/40 (2006.01), A61P 11/00 (2006.01), A61P 1